What is a PDUFA date?
The FDA's target date for deciding on a drug application — the single most-watched date in biotech.
PDUFA stands for the Prescription Drug User Fee Act. When the FDA accepts a New Drug Application (NDA) or Biologics License Application (BLA), it commits to a target action date, typically 6–10 months out (10 months standard review, 6 months priority).
A PDUFA date is not a guarantee of approval — the FDA can approve, issue a Complete Response Letter, or (rarely) delay — but it is the calendar anchor every biotech trader plans around, because decisions routinely move the stock 20–80% in a day.
Companies disclose PDUFA dates in 8-K filings and press releases; there is no structured free source, which is why our calendar extracts them from the filings themselves and links the exact sentence.
See it live: the catalyst calendar · status-change feed